Skip to main content
Top
Literature
1.
go back to reference Lovern D, Katzin B, Johnson K, Broadwell D, Miller E, Gates A, Deol P, Doing K, van Belkum A, Marshall C, Mathias E, Dunne WM Jr (2016) Antimicrobial binding and growth kinetics in BacT/ALERT® FA Plus and BACTEC® Aerobic/F Plus blood culture media. Eur J Clin Microbiol Infect Dis 35:2033–2036. doi:10.1007/s10096-016-2759-9 CrossRefPubMed Lovern D, Katzin B, Johnson K, Broadwell D, Miller E, Gates A, Deol P, Doing K, van Belkum A, Marshall C, Mathias E, Dunne WM Jr (2016) Antimicrobial binding and growth kinetics in BacT/ALERT® FA Plus and BACTEC® Aerobic/F Plus blood culture media. Eur J Clin Microbiol Infect Dis 35:2033–2036. doi:10.​1007/​s10096-016-2759-9 CrossRefPubMed
2.
go back to reference Goto M, Al-Hasan MN (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19:501–509CrossRefPubMed Goto M, Al-Hasan MN (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19:501–509CrossRefPubMed
3.
go back to reference Laupland KB (2013) Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect 19:492–500CrossRefPubMed Laupland KB (2013) Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect 19:492–500CrossRefPubMed
4.
go back to reference Laupland KB, Church DL (2014) Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 27:647–664CrossRefPubMedPubMedCentral Laupland KB, Church DL (2014) Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev 27:647–664CrossRefPubMedPubMedCentral
5.
go back to reference Søgaard M, Lyytikäinen O, Laupland KB, Schønheyder HC (2013) Monitoring the epidemiology of bloodstream infections: aims, methods and importance. Expert Rev Anti Infect Ther 11:1281–1290CrossRefPubMed Søgaard M, Lyytikäinen O, Laupland KB, Schønheyder HC (2013) Monitoring the epidemiology of bloodstream infections: aims, methods and importance. Expert Rev Anti Infect Ther 11:1281–1290CrossRefPubMed
6.
go back to reference Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D’Inzeo T, Fadda G, Cauda R, Spanu T (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51:1987–1994CrossRefPubMedPubMedCentral Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D’Inzeo T, Fadda G, Cauda R, Spanu T (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51:1987–1994CrossRefPubMedPubMedCentral
7.
go back to reference Barenfanger J, Graham DR, Kolluri L, Sangwan G, Lawhorn J, Drake CA, Verhulst SJ, Peterson R, Moja LB, Ertmoed MM, Moja AB, Shevlin DW, Vautrain R, Callahan CD (2008) Decreased mortality associated with prompt gram staining of blood cultures. Am J Clin Pathol 130:870–876CrossRefPubMed Barenfanger J, Graham DR, Kolluri L, Sangwan G, Lawhorn J, Drake CA, Verhulst SJ, Peterson R, Moja LB, Ertmoed MM, Moja AB, Shevlin DW, Vautrain R, Callahan CD (2008) Decreased mortality associated with prompt gram staining of blood cultures. Am J Clin Pathol 130:870–876CrossRefPubMed
8.
go back to reference Funk DJ, Kumar A (2011) Antimicrobial therapy for life-threatening infections: speed is life. Crit Care Clin 27:53–76CrossRefPubMed Funk DJ, Kumar A (2011) Antimicrobial therapy for life-threatening infections: speed is life. Crit Care Clin 27:53–76CrossRefPubMed
9.
go back to reference Dubourg G, Raoult D (2016) Emerging methodologies for pathogen identification in positive blood culture testing. Expert Rev Mol Diagn 16:97–111CrossRefPubMed Dubourg G, Raoult D (2016) Emerging methodologies for pathogen identification in positive blood culture testing. Expert Rev Mol Diagn 16:97–111CrossRefPubMed
10.
go back to reference Spaargaren J, van Boven CP, Voorn GP (1998) Effectiveness of resins in neutralizing antibiotic activities in bactec plus Aerobic/F culture medium. J Clin Microbiol 36:3731–3733PubMedPubMedCentral Spaargaren J, van Boven CP, Voorn GP (1998) Effectiveness of resins in neutralizing antibiotic activities in bactec plus Aerobic/F culture medium. J Clin Microbiol 36:3731–3733PubMedPubMedCentral
11.
go back to reference Chern IF, Steer JA, Wilson AP (1999) Effect of teicoplanin on isolation of Staphylococcus aureus from blood culture media. J Antimicrob Chemother 43:589–591CrossRefPubMed Chern IF, Steer JA, Wilson AP (1999) Effect of teicoplanin on isolation of Staphylococcus aureus from blood culture media. J Antimicrob Chemother 43:589–591CrossRefPubMed
12.
go back to reference Viganò EF, Vasconi E, Agrappi C, Clerici P, Melloni P (2004) Use of simulated blood cultures for antibiotic effect on time to detection of the two blood culture systems BacT/ALERT and BACTEC 9240. New Microbiol 27:235–248PubMed Viganò EF, Vasconi E, Agrappi C, Clerici P, Melloni P (2004) Use of simulated blood cultures for antibiotic effect on time to detection of the two blood culture systems BacT/ALERT and BACTEC 9240. New Microbiol 27:235–248PubMed
13.
go back to reference Flayhart D, Borek AP, Wakefield T, Dick J, Carroll KC (2007) Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics. J Clin Microbiol 45:816–821CrossRefPubMed Flayhart D, Borek AP, Wakefield T, Dick J, Carroll KC (2007) Comparison of BACTEC PLUS blood culture media to BacT/Alert FA blood culture media for detection of bacterial pathogens in samples containing therapeutic levels of antibiotics. J Clin Microbiol 45:816–821CrossRefPubMed
14.
go back to reference Miller NS, Rogan D, Orr BL, Whitney D (2011) Comparison of BD Bactec Plus blood culture media to VersaTREK Redox blood culture media for detection of bacterial pathogens in simulated adult blood cultures containing therapeutic concentrations of antibiotics. J Clin Microbiol 49:1624–1627. doi:10.1128/JCM.01958-10 CrossRefPubMedPubMedCentral Miller NS, Rogan D, Orr BL, Whitney D (2011) Comparison of BD Bactec Plus blood culture media to VersaTREK Redox blood culture media for detection of bacterial pathogens in simulated adult blood cultures containing therapeutic concentrations of antibiotics. J Clin Microbiol 49:1624–1627. doi:10.​1128/​JCM.​01958-10 CrossRefPubMedPubMedCentral
Metadata
Title
In vitro blood culture bottle inoculation of whole blood with clinically relevant antibiotic concentrations: a word of caution
Authors
M. Grupper
J. L. Kuti
D. P. Nicolau
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-016-2874-7

Other articles of this Issue 5/2017

European Journal of Clinical Microbiology & Infectious Diseases 5/2017 Go to the issue

Letter to the Editor

Author’s reply

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine